GRANULES — Granules India Share Price
- IN₹111.92bn
- IN₹120.71bn
- IN₹45.06bn
- 93
- 23
- 70
- 70
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | 17.7 | ||
PEG Ratio (f) | 0.8 | ||
EPS Growth (f) | 28.2% | ||
Dividend Yield (f) | 0.28% |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 3.2 | ||
Price to Tang. Book | 3.44 | ||
Price to Free Cashflow | 32.36 | ||
Price to Sales | 2.46 | ||
EV to EBITDA | 12.5 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | 19.61% | ||
Return on Equity | 14.99% | ||
Operating Margin | 16.44% |
Financial Summary
Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | IN₹m | 25,986.47 | 32,375.43 | 37,649.21 | 45,119.17 | 45,063.67 | 45,034.75 | 51,377.5 | 14.61% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +35.24 | +75.1 | -23.85 | +25.79 | -20.27 | +18.78 | +28.2 | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Granules India Limited is an India-based pharmaceutical manufacturing company. The Company operates through its pharmaceutical products segment. Its geographical segments include within India and outside India. The Company has a presence across the pharmaceutical manufacturing value chain, including active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediaries (PFIs) and finished dosages (FDs). It produces and supplies Paracetamol, Metformin, Guaifenesin, and Methocarbamol APIs. It has over 10 manufacturing facilities, approximately eight of which are located in India and two in the United States. The Company sells its products in global markets, including the United States of America, Canada, Latin America, Europe, Asia Pacific, and India. Its subsidiaries include Granules USA Inc and Granules Europe Limited. It also owns Senn Chemicals AG, a contract development and manufacturing organization (CDMO) specializing in peptide development and manufacturing.
Directors
- Sandip Neogi CFO
- Chaitanya Tummala CCO
- Chigurupati Prasad MDR (59)
- Harsha Chigurupati EDR (35)
- Uma Chigurupati EDR (53)
- Kolli Rao DRC
- Robert Cunard IND
- Arun Sawhney IND
- Arun Akinepally NID (55)
- Sucharita Palepu NID
- Last Annual
- March 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- March 18th, 1991
- Public Since
- September 20th, 1995
- No. of Shareholders
- 185,453
- No. of Employees
- 4,122
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
National Stock Exchange of India
- Shares in Issue
- 242,543,716

- Address
- 2nd Floor, HYDERABAD, 500081
- Web
- https://granulesindia.com/
- Phone
- +91 4069043500
- Auditors
- S.R. BATLIBOI & ASSOCIATES LLP
Upcoming Events for GRANULES
Q1 2026 Granules India Ltd Earnings Release
Granules India Ltd Annual Shareholders Meeting
Similar to GRANULES
Aarey Drugs and Pharmaceuticals
National Stock Exchange of India
Aarti Drugs
National Stock Exchange of India
Aarti Pharmalabs
National Stock Exchange of India
Abbott India
National Stock Exchange of India
Accent Microcell
National Stock Exchange of India
FAQ
As of Today at 20:55 UTC, shares in Granules India are trading at IN₹452.55. This share price information is delayed by 15 minutes.
Shares in Granules India last closed at IN₹452.55 and the price had moved by +8.28% over the past 365 days. In terms of relative price strength the Granules India share price has outperformed the S&P BSE 100 Index by +2% over the past year.
The overall consensus recommendation for Granules India is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Granules India dividend yield is 0.33% based on the trailing twelve month period.
Last year, Granules India paid a total dividend of IN₹1.50, and it currently has a trailing dividend yield of 0.33%. We do not have any data on when Granules India is to next pay dividends.
We do not have data on when Granules India is to next pay dividends. The historic dividend yield on Granules India shares is currently 0.33%.
To buy shares in Granules India you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of IN₹452.55, shares in Granules India had a market capitalisation of IN₹111.92bn.
Here are the trading details for Granules India:
- Country of listing: India
- Exchange: NSI
- Ticker Symbol: GRANULES
Based on an overall assessment of its quality, value and momentum Granules India is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Granules India is IN₹646.04. That is 42.76% above the last closing price of IN₹452.55.
Analysts covering Granules India currently have a consensus Earnings Per Share (EPS) forecast of IN₹19.95 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Granules India. Over the past six months, its share price has underperformed the S&P BSE 100 Index by -14.36%.
As of the last closing price of IN₹452.55, shares in Granules India were trading -19.88% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Granules India PE ratio based on its reported earnings over the past 12 months is 17.7. The shares last closed at IN₹452.55.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Granules India's management team is headed by:
- Sandip Neogi - CFO
- Chaitanya Tummala - CCO
- Chigurupati Prasad - MDR
- Harsha Chigurupati - EDR
- Uma Chigurupati - EDR
- Kolli Rao - DRC
- Robert Cunard - IND
- Arun Sawhney - IND
- Arun Akinepally - NID
- Sucharita Palepu - NID